跳至主要内容
临床试验/NCT04583930
NCT04583930Unknown不适用

Clinical and Health-related Outcome of rFVIIIFc Prophylaxis in Patients With Haemophilia A

Prof. Dr. Dr. Thomas Hilberg2 个研究点 分布在 1 个国家目标入组 48 人开始时间: 2021年2月1日最近更新:
适应症

试验速览

阶段
不适用
发起方
入组人数
48
试验地点
2
主要终点
total annual bleeding rate

研究概览

简要总结

Current standard therapy for patients with haemophilia (PwH) in the prevention of bleeding episodes is a prophylactic intravenous treatment with recombinant coagulation factor (F) VIII (Haemophilia A) or rather FIX (Haemophilia B) two to three times weekly. With the development of recombinant factor VIII Fc fusion protein (rFVIIIFc) the conventional routine prophylaxis regime is complemented by an extended half-life (EHL) factor replacement prophylaxis with the potential of improved bleed prevention and reduced injection frequency at similar factor consumption. Aim of this longitudinal multicentre study is to evaluate the influence of an EHL factor replacement regime with rFVIIIFc on haemophilic specific parameters (annual bleeding rate, bleeding localisation), joint status, pain, functional parameters, treatment adherence and health-related quality of life in PwH A.

研究设计

研究类型
Observational
观察模型
Cohort
时间视角
Prospective

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
Male
接受健康志愿者

入选标准

  • Patients suffering from moderate to severe haemophilia A
  • Age ≥ 18-years
  • Treatment with FVIII prophylaxis
  • Submitted written informed consent

排除标准

  • Patients suffering from other bleeding diseases
  • Patients with inhibitors
  • Patients without written informed consent
  • Age < 18-year-old
  • Any surgeries up to 6 months before the examination date
  • Suffering from different rheumatologic diseases like M. Bechterew, Psoriasis or other local or generalized joint infections (Borreliosis, septic arthritis)

结局指标

主要结局

total annual bleeding rate

时间窗: one year

number of total bleedings

orthopaedic joint status (Haemophilia health joint score)

时间窗: one year

The clinical joint status will be examined in all patients with haemophilia by the World Federation Joint Examination Score and Haemophilia Joint Health Score. Higher score points imply an increased deficit in the functional and structural joint status as a sign of more pronounced haemophilic arthropathy, with a maximum possible value of 124 (no deficits = 0).

pressure pain thresholds

时间窗: one year

physiological Parameter in Newton

次要结局

  • spontaneous joint ABR(one year)
  • subjective quality of life (SF-36)(two years)
  • subjective physical performance (HEP-Test-Q)(two years)
  • self-perceived functional abilities (Haemophilia Activities List)(two years)

研究者

发起方
Prof. Dr. Dr. Thomas Hilberg
申办方类型
Other
责任方
Sponsor Investigator
主要研究者

Prof. Dr. Dr. Thomas Hilberg

Head of Department

University of Wuppertal

研究点 (2)

Loading locations...

相似试验